Skip to Main Content
Insider Trading

Last Updated: 1 month, 1 week ago

Susan E Burwig has an estimated net worth of at least $54.1 million*, as of Oct. 29, 2025. They own 37,500 shares of MEDP stock. They have sold 85,002 shares of MEDP stock since 2021, for an estimated $14.7 million.

Susan E Burwig $MEDP SEC Form 4 Insider Trading

Susan E Burwig has filed a total of 10 insider trades in $MEDP since 2021. Their most recent trade was a sale of 20,000 shares, made on Nov 24, 2025. Their largest trade was a sale of 20,000 shares, made on Nov 24, 2025. We estimate that they now own 37,500 shares of $MEDP, worth an estimated $39.4 million.



Insider Trading at $MEDP

There have been a total of 306 insider trades reported at $MEDP since 2021, with 2.0 million shares purchased and 5.7 million shares sold. The most active insider traders in $MEDP stock have been August J. Troendle, August J. Troendle, and Susan E Burwig. The most recent trade was a sale of 668 shares reported by August J. Troendle (CEO), made on Dec 03, 2025.



History of Insider Stock Trades by Susan E Burwig

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
MEDP logo MEDP Sale 20,000 Nov 24, 2025 Nov. 26, 2025, 5:22 p.m.
MEDP logo MEDP Sale 18,000 Nov 11, 2025 Nov. 12, 2025, 11:10 a.m.
MEDP logo MEDP Sale 2,000 Oct 27, 2025 Oct. 29, 2025, 4:52 p.m.
MEDP logo MEDP Sale 10,000 Sep 03, 2025 Sept. 5, 2025, 4:16 p.m.
MEDP logo MEDP Sale 7,500 Jul 28, 2025 July 29, 2025, 5:43 p.m.
MEDP logo MEDP Sale 102 Mar 15, 2024 March 19, 2024, 5:11 p.m.
MEDP logo MEDP Sale 10,391 Dec 14, 2023 Dec. 18, 2023, 6:03 p.m.
MEDP logo MEDP Sale 2,009 Dec 15, 2023 Dec. 18, 2023, 6:03 p.m.
MEDP logo MEDP Sale 7,600 Jun 14, 2021 June 15, 2021, 8 p.m.
MEDP logo MEDP Sale 7,400 Jun 14, 2021 June 15, 2021, 8 p.m.




$MEDP Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.